Posted by Leslie Carol Botha November 23, 2010 When Cynthia Janak and I started out on the HPV vaccine research journey we were advised by an ex-FBI agent to watch our backs, to let people know what is going on, and to always let the public know what we are working on. Well, you all […]
New-Age Vaccine Adjuvants: Friend or Foe?
BioPharm International A major unsolved challenge in adjuvant development is how to achieve a potent adjuvant effect while avoiding reactogenicity or toxicity Aug 2, 2007 By: Nikolai Petrovsky, Susanne Heinzel, Yoshikazu Honda, A. Bruce Lyons BioPharm International ABSTRACT Older vaccines made from live or killed whole organisms were effective, but suffered from high reactogenicity. As vaccine manufacturers developed […]
Counseling helps patients start and complete HPV shot regimen
American Medical News Only 30% who begin the three-dose vaccine series actuallycomplete it, a new study says. By Christine S. Moyer, amednews staff. Posted Nov. 23, 2010. Educating female patients age 9 to 26 about the human papillomavirus vaccine could help bolster their protection against cervical cancer, the author of a new report says. Only […]
Is Your Friendly Neighborhood Blogger Pushing Drugs?
CBS Moneywatch.com By Marlys Harris | Nov 22, 2010 Could the blogger next door be accepting dough from big companies to shill their products? According to Kara McGuire, a staffer with the Minneapolis StarTribune, the answer is literally ‘yes.” Her recent story, “A New Recipe for the Web”, described General Mills’ efforts to promote its cake mixes […]
HPV test is next step for women
Mirror United Kingdom By Miriam Stoppard 22/11/2010 We’ve made great inroads in the fight against cervical cancer. Before the cervical screening programme was introduced in 1988, the death rate from the disease had tripled over 20 years. Now regular smear tests save an estimated 5,000 lives a year, according to the charity Cancer Research UK. […]
- « Previous Page
- 1
- …
- 201
- 202
- 203
- 204
- 205
- …
- 240
- Next Page »